Rekvina Laboratories Limited Share Price

Equities

VINRKLB

INE092O01028

Market Closed - Bombay S.E. Other stock markets 03:30:54 13/12/2021 pm IST			5-day change	1st Jan Change
4.5 ^INR	-.--%		-.--%	-.--%

11/06	Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	CI
11/06	Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	CI

Financials

Sales 2022	-	Sales 2023	-	Capitalization	27.13M 2.27B
Net income 2022	- 0	Net income 2023	- 0	EV / Sales 2022	-
Net cash position 2022	3.68K 308K	Net Debt 2023	716K 59.8M	EV / Sales 2023	-
P/E ratio 2022	-34.6 x	P/E ratio 2023	-3,641 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Rekvina Laboratories Limited

Duration

Period

Style

Dynamic Chart

Latest news about Rekvina Laboratories Limited

Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	11/06	CI
Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	11/06	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05	CI
Rekvina Laboratories Limited Appoints Pravin Chauhan as the Chief Financial Officer	22/05	CI
Rekvina Laboratories Limited Announces Management Changes	22/05	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Rekvina Laboratories Trims Net Loss in Fiscal Q4	08/23/08	MT
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Rekvina Laboratories Limited Appoints Bhavesh Prabhudas Vora as Non Executive, Additional Independent Director	14/22/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	07/22/07	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/21/11	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	23/21/23	CI

More news

Highs and lows

3 years

3.60

4.58

5 years

3.60

5.05

10 years

3.60

18.80

More quotes

Managers and Directors - Rekvina Laboratories Limited

Managers	Title	Age	Since
Mukeshbhai Jamnadas Shah CHM	Chairman	-	02/97/02
Akash Prajapati AUD	Comptroller/Controller/Auditor	-	03/23/03

Members of the board	Title	Age	Since
Mukeshbhai Jamnadas Shah CHM	Chairman	-	02/97/02
Amit Mukeshbhai Shah CEO	Chief Executive Officer	42	01/00/01
Bhavesh Prabhudas Vora BRD	Director/Board Member	57	14/22/14